HIV transmission through living donor kidney transplant: An 11-year follow-up on the recipient and donor [0.03%]
活体肾脏移植艾滋病毒传播：受者和供者的11年随访研究
Marcus R Pereira,Geoffrey K Dube,Luis Tatem et al.
Marcus R Pereira et al.
HIV transmission via solid organ transplant is a rare but serious complication. Here, we describe long-term outcomes in a case of living donor-derived transmission of HIV in a kidney transplant recipient. After 11 years since transplant sur...
Invasive fungal infection by Volvariella volvacea: First reported case following solid organ transplantation and a unique therapeutic approach [0.03%]
圣帖拉菌引起的侵袭性真菌感染：器官移植后的首例报告及独特治疗方法
Yi Da,Anantharaman Vathsala,Rachel Zui Chih Teo
Yi Da
Is it safe to perform abdominal transplantation from SARS-CoV-2 polymerase chain reaction positive donors? [0.03%]
SARS-CoV-2核酸检测阳性的供者可以用于腹部器官移植吗？
Paola Frattaroli,Shweta Anjan,Ana Coro et al.
Paola Frattaroli et al.
Early antimicrobial prophylaxis in autologous stem cell transplant recipients: Conventional versus an absolute neutrophil count-driven approach [0.03%]
自身干细胞移植受者中早期抗微生物预防的常规方法与绝对中性粒细胞计数驱动的方法的对比研究
Justin G Horowitz,Gerard W Gawrys,Grace C Lee et al.
Justin G Horowitz et al.
Background: Autologous hematopoietic stem cell transplantation (HSCT) recipients are at increased risk of developing life-threatening infections. There is discordance in published recommendations for timing of pre- and po...
Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients [0.03%]
器官移植或造血细胞移植受者感染巨细胞病毒的Letermovir治疗
Kathleen A Linder,Christopher Kovacs,Kate M Mullane et al.
Kathleen A Linder et al.
Background: Few options are available for cytomegalovirus (CMV) treatment in transplant recipients resistant, refractory, or intolerant to approved agents. Letermovir (LET) is approved for prophylaxis in hematopoietic cel...
Convalescent plasma treatment for early post-kidney transplant acquired COVID-19 [0.03%]
新冠感染的早期肾移植受者的恢复期血浆治疗
Malte A Kluger,Jan Czogalla,Christian Schmidt-Lauber et al.
Malte A Kluger et al.
The role of chronic suppressive antibiotics therapy in superficial drive line infection relapse of left ventricular assist devices: A retrospective cohort from a tertiary care center [0.03%]
左心室辅助装置浅表导管感染复发的慢性抑制性抗生素治疗的作用：一家三级护理中心的回顾性队列研究
Yasir Hamad,Merilda O Blanco-Guzman,Margaret A Olsen et al.
Yasir Hamad et al.
Introduction: Drive line infections (DLIs) are common complications of left ventricular assist devices (LVADs). Data on use of suppression antibiotic therapy are limited. ...
Lung transplant recipient attitudes and beliefs on accepting an organ that is positive for hepatitis C virus [0.03%]
有关接受阳性丙型肝炎病毒器官的肺移植受者的态度和信仰
Sapna S Humar,Natalia Pinzon,Marcelo Cypel et al.
Sapna S Humar et al.
Introduction: Little is known about patient perceptions regarding HCV+ organ use in non-HCV-infected recipients. This study examined factors influencing the decision to accept HCV+ organs and the resulting impacts. ...
A case report of successful kidney transplantation from a deceased donor with terminal COVID-19-related lung damage: Ongoing dilemma between discarding and accepting organs in COVID-19 era! [0.03%]
一例成功接受新冠肺炎终末期肺损伤供体肾脏移植的案例报道：新冠时代捐献还是拒绝器官的两难选择！
Hari Shankar Meshram,Vivek B Kute,Himanshu Patel et al.
Hari Shankar Meshram et al.
Interleukin-18 and tumor necrosis factor-α are elevated in solid organ transplant recipients with possible cytomegalovirus end-organ disease [0.03%]
实体器官移植受者疑似巨细胞病毒靶器官病的患者血浆中IL-18和肿瘤坏死因子水平升高
Andrew H Karaba,Alexis Figueroa,William A Werbel et al.
Andrew H Karaba et al.
End-organ cytomegalovirus (CMV) disease can be life threatening to solid organ transplant recipients. Diagnosis is often complicated by variation in amount of CMV DNA in plasma and the need for an invasive procedure to obtain a biopsy of th...